Literature DB >> 29734234

Two-Year Longitudinal Changes in Lower Limb Strength and Its Relation to Loss in Function in a Large Cohort of Patients With Duchenne Muscular Dystrophy.

Abhinandan Batra1, Ann Harrington, Donovan J Lott, Rebecca Willcocks, Claudia R Senesac, William McGehee, Dandan Xu, Sunita Mathur, Michael J Daniels, William D Rooney, Sean C Forbes, William Triplett, Jasjit K Deol, Ishu Arpan, Roxanne Bendixen, Richard Finkel, Erika Finanger, Gihan Tennekoon, Barry Byrne, Barry Russman, H Lee Sweeney, Glenn Walter, Krista Vandenborne.   

Abstract

OBJECTIVE: The main objective of this study was to examine the effect of disease on strength in two functionally important lower limb muscles for a period of 2 yrs in children with Duchene muscular dystrophy.
DESIGN: Seventy-seven Duchene muscular dystrophy children participated in this study. Plantar flexors, knee extensors, strength, and performance on timed tests (6-min walk, 4-stairs, 10-m walk, supine-up) were assessed yearly for 2 yrs. Multivariate normal regression was used to assess changes in strength over time in the Duchene muscular dystrophy group. Spearman correlations were computed to examine relationship between strength and function.
RESULTS: Normalized plantar flexor and knee extensor strength showed a significant decrease (P < 0.05) over 2 yrs, with larger declines in knee extensor. At baseline, knee extensor strongly correlated with performance on timed tests. However, plantar flexor strength was found to be a stronger predictor of loss in ambulatory function. Modest correlations (r = 0.19-0.34) were found between the decline in strength and functional performance over 2 yrs.
CONCLUSIONS: This study describes the loss of lower limb strength in a large cohort of Duchene muscular dystrophy children for 2 yrs. The findings support that lower limb strength alone cannot account for the decline in performance on functional tests, and the role of other contributing factors, such as compensatory strategies, should be considered.

Entities:  

Mesh:

Year:  2018        PMID: 29734234      PMCID: PMC6148402          DOI: 10.1097/PHM.0000000000000957

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  30 in total

Review 1.  Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors.

Authors:  Michael J Blankinship; Paul Gregorevic; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2005-12-19       Impact factor: 11.454

2.  Compensatory movements during functional activities in ambulatory children with Duchenne muscular dystrophy.

Authors:  Joyce Martini; Mariana Callil Voos; Michele Emy Hukuda; Maria Bernadete Dutra de Resende; Fátima Aparecida Caromano
Journal:  Arq Neuropsiquiatr       Date:  2014-01       Impact factor: 1.420

3.  Boys With Duchenne Muscular Dystrophy: 1-Year Locomotor Changes in Relation to a Control Group.

Authors:  Joyce Martini; Fátima Aparecida Caromano; Eduardo Vital Carvalho; Priscila Albuquerque Goya; Rosana Massae Hayasaka; Silvia Nakazune; Francis Meire Fávero; Mariana Callil Voos
Journal:  Percept Mot Skills       Date:  2017-11-24

Review 4.  Duchenne muscular dystrophy.

Authors:  Michael Sussman
Journal:  J Am Acad Orthop Surg       Date:  2002 Mar-Apr       Impact factor: 3.020

5.  Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients.

Authors:  Ernesto A C Beenakker; Natalia M Maurits; Johanna M Fock; Oebele F Brouwer; Johannes H van der Hoeven
Journal:  Eur J Paediatr Neurol       Date:  2005-08-15       Impact factor: 3.140

6.  The relationship of knee and ankle weakness to falls in nursing home residents: an isokinetic study.

Authors:  R H Whipple; L I Wolfson; P M Amerman
Journal:  J Am Geriatr Soc       Date:  1987-01       Impact factor: 5.562

7.  The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.

Authors:  Craig M McDonald; Erik K Henricson; Jay J Han; R Ted Abresch; Alina Nicorici; Gary L Elfring; Leone Atkinson; Allen Reha; Samit Hirawat; Langdon L Miller
Journal:  Muscle Nerve       Date:  2010-04       Impact factor: 3.217

8.  Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression.

Authors:  R J Willcocks; I A Arpan; S C Forbes; D J Lott; C R Senesac; E Senesac; J Deol; W T Triplett; C Baligand; M J Daniels; H L Sweeney; G A Walter; K Vandenborne
Journal:  Neuromuscul Disord       Date:  2014-01-11       Impact factor: 4.296

Review 9.  Novel approaches to corticosteroid treatment in Duchenne muscular dystrophy.

Authors:  Eric P Hoffman; Erica Reeves; Jesse Damsker; Kanneboyina Nagaraju; John M McCall; Edward M Connor; Kate Bushby
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-11       Impact factor: 1.784

10.  The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study.

Authors:  Craig M McDonald; Erik K Henricson; R Ted Abresch; Julaine M Florence; Michelle Eagle; Eduard Gappmaier; Allan M Glanzman; Robert Spiegel; Jay Barth; Gary Elfring; Allen Reha; Stuart Peltz
Journal:  Muscle Nerve       Date:  2013-06-26       Impact factor: 3.217

View more
  3 in total

1.  Walking activity in a large cohort of boys with Duchenne muscular dystrophy.

Authors:  Donovan J Lott; Tanja Taivassalo; Claudia R Senesac; Rebecca J Willcocks; Ann M Harrington; Kirsten Zilke; Hilary Cunkle; Catherine Powers; Erika L Finanger; William D Rooney; Gihan I Tennekoon; Krista Vandenborne
Journal:  Muscle Nerve       Date:  2020-11-27       Impact factor: 3.217

2.  Longitudinal changes in cardiac function in Duchenne muscular dystrophy population as measured by magnetic resonance imaging.

Authors:  Abhinandan Batra; Alison M Barnard; Donovan J Lott; Rebecca J Willcocks; Sean C Forbes; Saptarshi Chakraborty; Michael J Daniels; Jannik Arbogast; William Triplett; Erik K Henricson; Jonathan G Dayan; Carsten Schmalfuss; Lee Sweeney; Barry J Byrne; Craig M McDonald; Krista Vandenborne; Glenn A Walter
Journal:  BMC Cardiovasc Disord       Date:  2022-06-09       Impact factor: 2.174

3.  Safety, feasibility, and efficacy of strengthening exercise in Duchenne muscular dystrophy.

Authors:  Donovan J Lott; Tanja Taivassalo; Korey D Cooke; Hyunjun Park; Zahra Moslemi; Abhinandan Batra; Sean C Forbes; Barry J Byrne; Glenn A Walter; Krista Vandenborne
Journal:  Muscle Nerve       Date:  2020-12-22       Impact factor: 3.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.